Rosemary E. Teresi

613 total citations
10 papers, 494 citations indexed

About

Rosemary E. Teresi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Rosemary E. Teresi has authored 10 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Rosemary E. Teresi's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Renal cell carcinoma treatment (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Rosemary E. Teresi is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Renal cell carcinoma treatment (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Rosemary E. Teresi collaborates with scholars based in United States, United Kingdom and Germany. Rosemary E. Teresi's co-authors include Charis Eng, Kristin Waite, Frank Weber, Andrea Frilling, Christoph E. Broelsch, Ching‐Shih Chen, Krishna Chatterjee, Marcus G. Pezzolesi, Kevin Zbuk and Sarah M. Planchon and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The American Journal of Human Genetics and Human Molecular Genetics.

In The Last Decade

Rosemary E. Teresi

9 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemary E. Teresi United States 7 335 227 97 61 45 10 494
I‐Hsiao Chung Taiwan 16 446 1.3× 373 1.6× 82 0.8× 75 1.2× 25 0.6× 18 644
Haixia Guan China 10 177 0.5× 122 0.5× 168 1.7× 84 1.4× 26 0.6× 24 361
Xiaomai Zhou China 4 353 1.1× 110 0.5× 160 1.6× 117 1.9× 17 0.4× 7 469
Maria Luisa Nicolosi Italy 14 319 1.0× 160 0.7× 256 2.6× 184 3.0× 35 0.8× 14 606
Jiadong Wang China 10 337 1.0× 222 1.0× 57 0.6× 91 1.5× 46 1.0× 15 458
Jeff Bruce Canada 7 515 1.5× 422 1.9× 63 0.6× 57 0.9× 21 0.5× 8 681
James M. Arnold United States 10 269 0.8× 219 1.0× 33 0.3× 78 1.3× 39 0.9× 11 408
Donatella Amendola Italy 10 147 0.4× 108 0.5× 68 0.7× 59 1.0× 86 1.9× 13 335
Andrea Luchin Italy 7 304 0.9× 247 1.1× 130 1.3× 104 1.7× 43 1.0× 8 507
Guohe Song China 10 216 0.6× 142 0.6× 49 0.5× 131 2.1× 51 1.1× 19 471

Countries citing papers authored by Rosemary E. Teresi

Since Specialization
Citations

This map shows the geographic impact of Rosemary E. Teresi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary E. Teresi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary E. Teresi more than expected).

Fields of papers citing papers by Rosemary E. Teresi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary E. Teresi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary E. Teresi. The network helps show where Rosemary E. Teresi may publish in the future.

Co-authorship network of co-authors of Rosemary E. Teresi

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary E. Teresi. A scholar is included among the top collaborators of Rosemary E. Teresi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary E. Teresi. Rosemary E. Teresi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Szabados, Bernadett, Félix Guerrero‐Ramos, Enrique Grande, et al.. (2025). On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC. Oncology and Therapy. 13(2). 275–291.
2.
Choueiri, Toni K., Amber C. Donahue, David A. Braun, et al.. (2023). Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma. Cancer Discovery. 14(3). 406–423. 6 indexed citations
3.
Rini, Brian I., Michael B. Atkins, Toni K. Choueiri, et al.. (2023). Plain Language Summary Looking at How Long Side Effects Last After Treatment with Axitinib is Stopped in People with Advanced Renal Cell Carcinoma. Future Oncology. 19(40). 2623–2629. 1 indexed citations
4.
Burns, Kathleen H., Nancy P. Moldawer, Meghara Walsh, et al.. (2023). The Role of Nurses in the Management of Adverse Events in Patients Receiving First-Line Axitinib Plus Immuno-Oncology Agents for Advanced Renal Cell Carcinoma. Seminars in Oncology Nursing. 40(1). 151545–151545. 2 indexed citations
5.
Teresi, Rosemary E. & Kristin Waite. (2008). PPARγ, PTEN, and the Fight against Cancer. PPAR Research. 2008(1). 932632–932632. 33 indexed citations
6.
Bennett, Kristi L., Todd Romigh, Khelifa Arab, et al.. (2008). Activator protein 2 alpha (AP2α) suppresses 42 kDa C/CAAT enhancer binding protein α (p42C/EBPα) in head and neck squamous cell carcinoma. International Journal of Cancer. 124(6). 1285–1292. 12 indexed citations
7.
Teresi, Rosemary E., Kevin Zbuk, Marcus G. Pezzolesi, Kristin Waite, & Charis Eng. (2007). Cowden Syndrome–Affected Patients with PTEN Promoter Mutations Demonstrate Abnormal Protein Translation. The American Journal of Human Genetics. 81(4). 756–767. 67 indexed citations
8.
Teresi, Rosemary E., Sarah M. Planchon, Kristin Waite, & Charis Eng. (2007). Regulation of the PTEN promoter by statins and SREBP. Human Molecular Genetics. 17(7). 919–928. 39 indexed citations
9.
Weber, Frank, Rosemary E. Teresi, Christoph E. Broelsch, Andrea Frilling, & Charis Eng. (2006). A Limited Set of Human MicroRNA Is Deregulated in Follicular Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 91(9). 3584–3591. 237 indexed citations
10.
Teresi, Rosemary E., et al.. (2006). Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone. International Journal of Cancer. 118(10). 2390–2398. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I‐Hsiao Chung Breakdown of academic impact, for papers by Haixia Guan Breakdown of academic impact, for papers by Xiaomai Zhou Breakdown of academic impact, for papers by Maria Luisa Nicolosi Breakdown of academic impact, for papers by Jiadong Wang Breakdown of academic impact, for papers by Jeff Bruce Breakdown of academic impact, for papers by James M. Arnold Breakdown of academic impact, for papers by Donatella Amendola Breakdown of academic impact, for papers by Andrea Luchin Breakdown of academic impact, for papers by Guohe Song
Rankless by CCL
2026